Details.
A study investigating an experimental new medicine for treating macular degeneration. For healthy male or female participants aged 18 to 65. Participation involves 3 nights and up to 9 outpatient visits. Admissions are on 24 August and 28 September 2026. Study payment is £3,250 to £8,500.